text: SK-Br3 cells cultured in the presence of topoisomerase IIalpha (<< TOP2A >>) inhibitors doxorubicin and [[ etopoxide ]] (VP-16) demonstrated a 2- to 3-fold increase in FAS promoter activity when compared with control cells growing in drug-free culture conditions.